C8B Chromosome 1
Complement C8 beta chain
Upload your DNA to see your personal genotypes for variants in C8B.
What This Gene Does
This gene encodes one of the three subunits of the complement component 8 (C8) protein. C8 is composed of equimolar amounts of alpha, beta and gamma subunits, which are encoded by three separate genes. C8 is one component of the membrane attack complex, which mediates cell lysis, and it initiates membrane penetration of the complex. This protein mediates the interaction of C8 with the C5b-7 membrane attack complex precursor. In humans deficiency of this protein is associated with increased risk of meningococcal infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
Gene Info
Gene Group
"Complement system activation components|Membrane Attack complex"
Locus Type
gene with protein product
Location
1p32.2
Ensembl
ENSG00000021852
Associated Conditions (5)
Type II complement component 8 deficiency
Inborn genetic diseases
Cholangiocarcinoma
Complement component 6 deficiency
C8B-related disorder
Key Variants
RS116348786
Conflicting classifications of pathogenicity
Type II complement component 8 deficiency, Type II complement component 8 deficiency
Health Risk
RS144586148
Conflicting classifications of pathogenicity
Type II complement component 8 deficiency, Inborn genetic diseases, Type II complement component 8 deficiency
Health Risk
RS150022116
Conflicting classifications of pathogenicity
Type II complement component 8 deficiency, Type II complement component 8 deficiency
Health Risk
RS369993264
Conflicting classifications of pathogenicity
Type II complement component 8 deficiency, Inborn genetic diseases, Type II complement component 8 deficiency
Health Risk
RS377623911
Conflicting classifications of pathogenicity
Type II complement component 8 deficiency, Inborn genetic diseases, Type II complement component 8 deficiency
Health Risk
RS760472969
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS774792617
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS139498867
Likely benign; association
Health Risk
RS1394604123
Likely pathogenic
Health Risk
RS1398395381
Likely pathogenic
Health Risk
RS1557725222
Likely pathogenic
Health Risk
RS1644937659
Likely pathogenic
Health Risk
All Variants (46)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS116348786 | Health Risk | Conflicting classifications of pathogenicity | Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS144586148 | Health Risk | Conflicting classifications of pathogenicity | Type II complement component 8 deficiency, Inborn genetic diseases, Type II complement component 8 deficiency |
| RS150022116 | Health Risk | Conflicting classifications of pathogenicity | Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS369993264 | Health Risk | Conflicting classifications of pathogenicity | Type II complement component 8 deficiency, Inborn genetic diseases, Type II complement component 8 deficiency |
| RS377623911 | Health Risk | Conflicting classifications of pathogenicity | Type II complement component 8 deficiency, Inborn genetic diseases, Type II complement component 8 deficiency |
| RS760472969 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS774792617 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS139498867 | Health Risk | Likely benign; association | — |
| RS1394604123 | Health Risk | Likely pathogenic | — |
| RS1398395381 | Health Risk | Likely pathogenic | — |
| RS1557725222 | Health Risk | Likely pathogenic | — |
| RS1644937659 | Health Risk | Likely pathogenic | — |
| RS2101487641 | Health Risk | Likely pathogenic | — |
| RS2522795281 | Health Risk | Likely pathogenic | — |
| RS766080403 | Health Risk | Likely pathogenic | Cholangiocarcinoma, Cholangiocarcinoma |
| RS1175509707 | Health Risk | Pathogenic | — |
| RS140813121 | Health Risk | Pathogenic | Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS1428653006 | Health Risk | Pathogenic | — |
| RS1464732473 | Health Risk | Pathogenic | — |
| RS1467702188 | Health Risk | Pathogenic | — |
| RS1557743907 | Health Risk | Pathogenic | — |
| RS1645249331 | Health Risk | Pathogenic | — |
| RS200077558 | Health Risk | Pathogenic | — |
| RS2101385559 | Health Risk | Pathogenic | — |
| RS2101408848 | Health Risk | Pathogenic | — |
| RS2522722829 | Health Risk | Pathogenic | — |
| RS2522731492 | Health Risk | Pathogenic | — |
| RS2522747844 | Health Risk | Pathogenic | — |
| RS2522748423 | Health Risk | Pathogenic | — |
| RS2522772830 | Health Risk | Pathogenic | — |
| RS372968576 | Health Risk | Pathogenic | Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS374155702 | Health Risk | Pathogenic | Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS398122867 | Health Risk | Pathogenic | Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS398122868 | Health Risk | Pathogenic | Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS41286844 | Health Risk | Pathogenic | Type II complement component 8 deficiency, Complement component 6 deficiency, C8B-related disorder |
| RS529668782 | Health Risk | Pathogenic | — |
| RS752754320 | Health Risk | Pathogenic | — |
| RS753002884 | Health Risk | Pathogenic | Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS759074976 | Health Risk | Pathogenic | Type II complement component 8 deficiency, Type II complement component 8 deficiency |
| RS760669928 | Health Risk | Pathogenic | — |
| RS773716735 | Health Risk | Pathogenic | — |
| RS780667562 | Health Risk | Pathogenic | — |
| RS866880466 | Health Risk | Pathogenic | — |
| RS1176902020 | Health Risk | Pathogenic/Likely pathogenic | C8B-related disorder, C8B-related disorder |
| RS146187042 | Health Risk | Pathogenic/Likely pathogenic | Type II complement component 8 deficiency, Complement component 6 deficiency, C8B-related disorder |
| RS779205550 | Health Risk | Pathogenic/Likely pathogenic | Type II complement component 8 deficiency, Type II complement component 8 deficiency |